Christopher M. Koth

Christopher M. Koth

Auto-generated profile, based on publicly available information

Christopher M. Koth

Department of Structural Biology, Genentech Inc., South San Francisco, CA 94080, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
BLBenjamin E. L. Lauffer
Benjamin E. L. Lauffer
RMRobert Mintzer
Robert Mintzer
RFRina Fong
Rina Fong
SMSusmith Mukund
Susmith Mukund
CTChristine Tam
Christine Tam
PSPascal Steiner
Pascal Steiner
Histone deacetylases (HDACs) are critical in the control of gene expression, and dysregulation of their activity has been implicated in a broad range of diseases, including cancer, cardiovascular, and neurological diseases. HDAC inhibitors (HDACi) employing different zinc chelating functionalities such as hydroxamic acids and benzamides have shown promising results in cancer therapy. Although it has also been suggested that HDACi with increased isozyme selectivity and potency may broaden their clinical utility and minimize side effects, the translation of this idea to the clinic remains to be investigated. Moreover, a detailed understanding of how HDACi with different pharmacological properties affect biological functions in vitro and in vivo is still missing. Here, we show that a panel of benzamide-containing HDACi are slow tight-binding inhibitors with long residence times unlike the hydroxamate-containing HDACi vorinostat and trichostatin-A. Characterization of changes in H2BK5 and H4K14 acetylation following HDACi treatment in the neuroblastoma cell line SH-SY5Y revealed that the timing and magnitude of histone acetylation mirrored both the association and dissociation kinetic rates of the inhibitors. In contrast, cell viability and microarray gene expression analysis indicated that cell death induction and changes in transcriptional regulation do not correlate with the dissociation kinetic rates of the HDACi. Therefore, our study suggests that determining how the selective and kinetic inhibition properties of HDACi affect cell function will help to evaluate their therapeutic utility.

18 December 2015 in Science
Verified
Journal Article
Closed access
PDF file
SAShivani Ahuja
Shivani Ahuja
SMSusmith Mukund
Susmith Mukund
LDLunbin Deng
Lunbin Deng
KKKuldip Khakh
Kuldip Khakh
ECElaine Chang
Elaine Chang
JPJian Payandeh
Jian Payandeh
A channel involved in pain perception: Voltage-gated sodium (Nav) channels propagate electrical signals in muscle cells and neurons. In humans, Nav1.7 plays a key role in pain perception. It is challenging to target a particular Nav isoform; however, arylsulfonamide antagonists selective for Nav1.7 have been reported recently. Ahuja et al. characterized the binding of these small molecules to human Nav channels. To further investigate the mechanism, they engineered a bacterial Nav channel to contain features of the Nav1.7 voltage-sensing domain that is targeted by the antagonist and determined the crystal structure of the chimera bound to an inhibitor. The structure gives insight into the mechanism of voltage sensing and will enable the design of more-selective Nav channel antagonists. Science , this issue p. 10.1126/science.aac5464

30 September 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
Angel RayaAngel Raya
Angel Raya
CKChristopher M. Koth
Christopher M. Koth
DBDirk Büscher
Dirk Büscher
YKYasuhiko Kawakami
Yasuhiko Kawakami
TITohru Itoh
Tohru Itoh
Juan Carlos Izpisua BelmonteJuan Carlos Izpisua Belmonte
Juan Carlos Izpisua Belmonte
Several vertebrates display the ability to regenerate parts of their body after amputation. During this process, differentiated cells reenter the cell cycle and proliferate to generate a mass of undifferentiated cells. Repatterning mechanisms act on these cells to eventually shape a regenerated tissue or organ that replaces the amputated one. Experiments with regenerating limbs/fins in newts and zebrafish have shown that members of the Msx family of homeodomain-containing transcription factors play key roles during blastema formation and patterning. Here we show that adult zebrafish have a remarkable capacity to regenerate the heart in a process that involves up-regulation of msxB and msxC genes. We present evidence indicating that heart regeneration involves the execution of a specific genetic program, rather than redeployment of a cardiac development program. Preceding Msx activation, there is a marked increase in the expression of notch1b and deltaC , which we show are also up-regulated during fin regeneration. These data suggest a role for the Notch pathway in the activation of the regenerative response. Taken together, our results underscore the use of zebrafish as a model for investigating the process of regeneration in particular and the biology of stem cells in general. Advances in these fields will undoubtedly aid in the implementation of strategies for regenerative medicine.

27 May 2003 in Nature Cell Biology
Verified
Journal Article
Closed access
YKYasuhiko Kawakami
Yasuhiko Kawakami
Joaquín Rodríguez-LeónJoaquín Rodríguez-León
Joaquín Rodríguez-León
CKChristopher M. Koth
Christopher M. Koth
DBDirk Büscher
Dirk Büscher
TITohru Itoh
Tohru Itoh
JBJuan Carlos Izpisúa Belmonte
Juan Carlos Izpisúa Belmonte

6 April 2006 in Nature
Verified
Journal Article
Closed access
PDF file
VLVladimir V. Lunin
Vladimir V. Lunin
EDElena Dobrovetsky
Elena Dobrovetsky
GKGalina Khutoreskaya
Galina Khutoreskaya
RZRongguang Zhang
Rongguang Zhang
AJAndrzej Joachimiak
Andrzej Joachimiak
CKChristopher M. Koth
Christopher M. Koth

13 March 2020 in Science
Verified
Journal Article
Closed access
PDF file
LRLionel Rougé
Lionel Rougé
NCNancy Chiang
Nancy Chiang
MSMicah Steffek
Micah Steffek
CKChristine Kugel
Christine Kugel
TCTristan I. Croll
Tristan I. Croll
ARAlexis Rohou
Alexis Rohou
Clustering for the kill: Cluster of differentiation 20 (CD20) is a membrane protein that defines most B cell populations and is the target of therapeutic antibodies to treat malignancies and autoimmune disorders. Rougé et al. present the structure of CD20 bound to the antibody rituximab that activates the complement system to kill B cells. CD20 forms a dimer and each monomer binds one rituximab antigen-binding fragment (Fab) to give 2:2 stoichiometry. The compact packing between Fab arms and CD20 gives rise to circular assemblies with a diameter similar to that of antibody hexamers known to recruit the first component of the complement cascade. Science , this issue p. 1224